Abrdn is in advanced talks with Citic Bank to establish an asset management joint venture in China, according to sources familiar with the matter. The British asset manager aims to expand in the world’s second-largest economy, bucking the trend of Western firms retreating due to economic uncertainties and U.S.-China tensions.
The UK’s second-largest independent asset manager is expected to hold a majority stake in the venture, while Citic Wealth, Citic Bank’s wealth management arm, will own the remaining share. Citic Wealth, China’s third-largest bank-owned wealth unit, manages 2 trillion yuan ($275 billion) in assets as of last year.
These discussions gained momentum following the recent revival of high-level economic and financial talks between China and the UK after nearly six years of stagnation. Abrdn and Citic Bank have been exploring collaboration for years, including options such as forming a mainland China venture or Abrdn acquiring a stake in Citic Wealth.
The move comes as the UK-China relationship shows signs of improvement, diverging from other Western financial firms that have cut jobs or scaled back expansion plans in China. The partnership would mark a significant step for Abrdn in strengthening its foothold in the Chinese market.
Neither Abrdn nor Citic Bank has commented on the discussions. Citic Bank, a key financial institution under China’s state-owned Citic Group, has yet to respond to inquiries.
By entering China’s growing wealth management sector, Abrdn seeks to capitalize on opportunities in the $275 billion market, reinforcing its global strategy despite ongoing economic uncertainties.


Ukrainian Drone Makers Target Japan and Asia Defense Market
SK Hynix Shares Hit Record High After Shipping Next-Generation HBM4E AI Memory Samples
China Adds MP Materials, USA Rare Earth to Export Control List Amid Escalating U.S.-China Trade Tensions
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation
JPMorgan Sees Strong Strategic Value in Potential AbbVie Acquisition of Apogee Therapeutics
Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race
US Raises Concerns Over Possible ASML EUV Machine Transfer to China
Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag
Saudi Aramco Explores Sulphur Business Stake Sale to Raise Billions
Frank Stronach Found Guilty of Sexual Assault and Indecent Assault in Ontario Court
HSBC Australia Faces A$35M Penalty Over Scam Protection Failures
Kingboard Holdings Shares Surge After HK$11.77 Billion Block Trade to Expand PCB and AI Supply Chain Business
Samsung Gains Interest from BYD, Google, AMD as AI Chip Demand Strains TSMC Capacity
J.P. Morgan Sees Potential Vestas Guidance Upgrade Amid Strong Wind Energy Demand
TD Bank Expands Employee Monitoring Software to Boost Productivity Amid Privacy Concerns
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks 



